Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
PAI1 mediates fibroblast–mast cell interactions in skin fibrosis
Neha Pincha, … , Paul Mazhuvanchary Jacob, Colin Jamora
Neha Pincha, … , Paul Mazhuvanchary Jacob, Colin Jamora
Published March 26, 2018
Citation Information: J Clin Invest. 2018;128(5):1807-1819. https://doi.org/10.1172/JCI99088.
View: Text | PDF
Research Article Cell biology Inflammation

PAI1 mediates fibroblast–mast cell interactions in skin fibrosis

  • Text
  • PDF
Abstract

Fibrosis is a prevalent pathological condition arising from the chronic activation of fibroblasts. This activation results from the extensive intercellular crosstalk mediated by both soluble factors and direct cell-cell connections. Prominent among these are the interactions of fibroblasts with immune cells, in which the fibroblast–mast cell connection, although acknowledged, is relatively unexplored. We have used a Tg mouse model of skin fibrosis, based on expression of the transcription factor Snail in the epidermis, to probe the mechanisms regulating mast cell activity and the contribution of these cells to this pathology. We have discovered that Snail-expressing keratinocytes secrete plasminogen activator inhibitor type 1 (PAI1), which functions as a chemotactic factor to increase mast cell infiltration into the skin. Moreover, we have determined that PAI1 upregulates intercellular adhesion molecule type 1 (ICAM1) expression on dermal fibroblasts, rendering them competent to bind to mast cells. This heterotypic cell-cell adhesion, also observed in the skin fibrotic disorder scleroderma, culminates in the reciprocal activation of both mast cells and fibroblasts, leading to the cascade of events that promote fibrogenesis. Thus, we have identified roles for PAI1 in the multifactorial program of fibrogenesis that expand its functional repertoire beyond its canonical role in plasmin-dependent processes.

Authors

Neha Pincha, Edries Yousaf Hajam, Krithika Badarinath, Surya Prakash Rao Batta, Tafheem Masudi, Rakesh Dey, Peter Andreasen, Toshiaki Kawakami, Rekha Samuel, Renu George, Debashish Danda, Paul Mazhuvanchary Jacob, Colin Jamora

×

Figure 1

PAI1 contributes to fibrosis in Snail-Tg skin.

Options: View larger image (or click on image) Download as PowerPoint
PAI1 contributes to fibrosis in Snail-Tg skin.
(A) qPCR for SNAIL and PA...
(A) qPCR for SNAIL and PAI1 in skin samples from healthy individuals (Non-SSc) and scleroderma patients (SSc) (n = 4). (B) Western blot for PAI1 in WT and Snail-Tg epidermis and quantification. β-Actin was used as a loading control (n = 3). (C) Reverse transcriptase PCR of Pai1 in WT and Snail-Tg keratinocytes (n = 3). (D) WT, Snail-Tg (Sn tg), and Snail-Tg/Pai1-KO (Sn tg/PAI1 KO) neonatal skin analyzed for PAI1 secretion by immunostaining (n = 3). Scale bar: 50 μm. (E–H) WT, Snail-Tg, and Snail-Tg/Pai1-KO adult skin sections were analyzed for (E) dermal thickness by quantitation of H&E-stained sections (n = 4); (F) Col1, -3, -4, and -7 by qPCR (n = 3); (G) collagen protein levels by hydroxyproline assay (n = 5); and (H) miR29a 3p levels by qPCR (n = 3). Data represent the mean ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001, by Student’s t test (A and B) and 1-way ANOVA followed by Tukey’s post hoc analysis (E–H).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts